CUMULATIVE INDEX 2000 Volume 18 March GERIATRIC ANESTHESIA, pages 1-215 June REGIONAL ANESTHESIA, pages 217-493 September PERIOPERATIVE MEDICINE, pages 495-703 December ANESTHESIA AND RENAL CONSIDERATIONS, pages 705-994 \ Vote: Page numbers of article and issue titles are in boldface type Accounting, in business of perioperative Acute tubular necrosis, in pathogenesis of medicine, 679-684 renal insufficiency, 778-779 Acetaminophen, as analgesic agent in prerenal syndrome and, interface be- palliative care, 187 tween, 741-742 \cid-base and electrolyte changes, as vasomotor nephropathy, 798-799 physiologic, in acute and chronic Adenosine, in cardiopulmonary renal failure patients, 809-833 resuscitation in the elderly, 152 hyperkalemia, 819-821, 822 Advance care planning, 201 hypermagnesemia, 828-829 Advanced age, as risk factor for acute hypernatremia, 817-819 renal failure, 707 hyperphosphatemia, 829-830 Advance directives, 164-167, 201 hypocalcemia, 821, 823-826 Airway(s), in geriatric patients, and effect hypomagnesemia, 826-828 on cardiopulmonary resuscitation, hyponatremia, 813-817 148-149 metabolic acidosis, 810-813 upper and lower, structural alterations Acute care medicine, community hospital in, in elderly, 48-49 practice, 539-550 Albumin, in kidney transplant surgery, availability of services, 544 935-937 critical care, 543-544 Alfentanil, as opioid analgesic, 261 hospital organization involvement, pharmacology of, in elderly patients, 544-545 14-15 intraoperative care, 541 Ambulation, with neuraxial labor opportunities for anesthesiologists in analgesia, 392-393 acute care hospitals, 547 Ambulatory surgery, outcomes research in, postoperative care, 542 639-640 preoperative evaluation clinic, 540-541 regional anesthesia for, 341-353 recruiting and training of advantages of, 341-342 anesthesiologists, 545 paravertebral block, 347-348 success of perioperative medicine, techniques, 342-347 545-547 thoracic paravertebral block, 352-353 surgical clinical pathways, 542-543 spinal anesthesia for, 237 uncertain future for anesthesiology, Amides, for local anesthesia, bupivacaine, 549-550 228-229 working with hospitalist teams, dibucaine, 229-230 547-549 etidocaine, 229 Acute cortical necrosis, in pathogenesis of levobupivacaine, 230 renal insufficiency, 779 lidocaine, 226-227 974 CUMULATIVE INDEX 2000 Amides (Continued) Aortic stents, endovascular, for prevention 2 72 mepivacaine, 227-228 of renal failure, 733-73 prilocaine, 229 Aortic surgery, difficulties with assessing ropivacaine, 230 literature on perioperative renal Aminosteroids, for renal preservation, 764 protection during, 725-72¢ ) Amiodreasruosncei,t atiionn cainr dtihoep uellmdeornlay,r y 15 >, ] difficmuletnite s ofw itrehn ali ntfruanocpteiroant ivdeu riansgs,e ss7-2 0 Ammonia toxicity, as complication ot 723 transurethral resection of prostate intraoperative management of renal func- 892-893 tion during, 719-737 Analgesia, balanced, 585 with endovascular aortic stents — labor. See Labor analges 734 pre-emptive, 585 historical perspective 719 720 from regional anesthesia, 98 with kidney perfusate, 74 3229 -4973232 Analgesics, nonopioid, for postoperative with pharmacologic agents, calcium pain management, in pediatric patients, 622 623 channel blockers, 731 dopamine, 729-731r i non-opioid, in palliative care, 187, 189 opioid, in palliative care, 189-194 furosemide 728-729 for pions tpoepdeiraattriicv e paptaiienn ts,m an6a2g4-e6m2e6n t witmha nnviotlolu,m e 72l6oa-d7i2n8g , 731 =4 5 5 Anaritide, for prevention of acute re nal renal dysfunction caused by > ve) failure, 713 Apnea, as intubation-related complication Anemia, chronic, preoperative evaluation in pediatric patients, 616-617 for kidney transplant surgery, 925-926 postoperative, in premature infants 604 in patients with chronic renal failure 605 SOY isk for anesthesia in pediatric pa- Anesthesiologists, opportunities for, in tients, 606—607 acute care hospitals, 547 Arginine vasopressin, for septic shock recruiting and training, in community 801-802 hospital practice, 545 vasoconstrictor response and, 794-795 Anesthesiology, common problem and Arrhythmias, in patients with chronic special problem in, 519-520 renal failure, 879 outcomes in perioperative medicine and Arterial stiffening, as effect of 633-645. See also Perioperati 1 cine, and anesth' esioOll) o gi c3a5r-3d6i ovascular and autonomic aging Anesthetic drugs, pharmacology of, i elderly patients. See P/ Arthritis, affecting positioning of aged mesthtehteitc drugs, in ’ elderly pa patients, 108-109 Aneurysm, abdominal aortic Artificial nutrition and hydration, in extracorporeal shock wave hotripsy terminally ill, 202-203 963-964 Asthma, as risk for anesthesia in pediatric Angiotensin-converting enzyme inhibitors patients, 603-604 vasomotor nephropa 7t hy from, 804-805 Atracurium, pharmacology of, in elderly Ankle, nerve blocks at, 33,]3 -334 patients, 23 Anterior spinal artery syndrome, as Atrial natriuretic peptide, for oliguria complication of spinal and epidural 747-748 anesthesia, 468 for renal preservation, 759-761 Antiarrhythmics, in cardiopulmonary vasodilator response and, 796 resuscitation in the elderly, 152-153 Atrial natriuretic peptide analogues, for Anticoagulation, oral, spinal hematoma prevention of acute renal failure, 713 and, 472-473 spinal anesthesia and, 238 239 Atropine, decreased response to, as effect Antimicrobial agents, as risk factor for of cardiovascular and autonomic acute renal failure, 708 aging, 38 Antiplatelet medications, spinal hematoma Autonomic and cardiovascular function, in and, 473-474 geriatric patient, 31-46 Anuria intraoperative, causesof , In effects of anesthesia and kidney transplant surgery, 939-940 hemodynamic management Aortic cross-clamping, as risk factor for 40-43 acute renal failure, 710 management of hypotension, 42-43 CUMULATIVE INDEX 2000 975 mechanisms of cardiovascular and Cardiac disease, preoperative evaluation, autonomic aging, changes in for kidney transplant surgery, 922 sympathetic nervous system Cardiac dysfunction, as risk factor for 38-39 acute renal failure, 707 connective tissue stiffening, Cardiac stiffening, as effect of decreased beta-receptor cardiovascular and autonomic aging, responsiveness, 32-35 37-38 decreased response to atropine, 38 Cardiopulmonary bypass, as risk factor for Axillary blockade, for upper extremity acute renal failure, 710 regional anesthesia, 311-312 vasomotor nephropathy from, 803-804 Cardiopulmonary resuscitation, decision not to initiate, in terminally ill, 202 management of, 143-158 Back pain, lower, management of, in outcome of, in elderly patients, 144-147 geriatric patients 128-131 patients expectations, 154 Bacteremia, transient, as complication of physiologic changes with aging and ef- transurethral resection of prostate, 893 fects on, 147-153 nzocaine, for local anesthesia, 226 airway, 148-149 ement, 203-204 cerebral protection, 153 CE ptor responsliv eness, decreased, as circulation, 149-150 effect of cardiovascular aging, 32-35 drug therapy, 150-153 Bladder, neuroanatomy of, 885-886 ardiovascular complications, from kidney toraat tion of, as complication of trans transplant surgery, 940 urethral resection of prostate, 893 ardiovascular disease, outcomes research Bleeding, as complication of transurethral in, 638-639 resection of prostate, 894 in patients with chronic renal failure, Blockade » of stellate ganglion, for chronic 868 pain management, 442-445 ardiovascular function, autonomic and, rid od loss, with epidural anesthesia and in geriatric patient. See Autonomic and inalgesia, 423 cardil ovvaa) sculalra functifaol n , in geriatric Blood transfusion, preoperatiy e, for patient patients with chronic renal failure ase-controlled trials, in outcomes 875 research, 636 affected by extracorporeal shock atheters, for combined spinal-epidural wave lithotripsy, 963 technique risk of penetration from, | obstruction, in terminally ill 276-277 patients, 196 for epidural anesthesia, 252 i achial plexus block, in pediatrics insertion techniques, 252-254 verification of location, 254-255 Brain damage, as cause of CNS audal anesthesia, for transurethral dysfunction after anesthesia, 60 resection of prostate, 858 Bronchopulmonary dysplasia, as risk for audal block, in pediatrics, 356-359 anesthesia in pediatric patients, dosing, 358-359 605-606 equipment, 357 Bupivacaine, for epidural anesthesia, 260 risks, complications, contraindications, 261 359 for local anesthesia, 228-229 technique, 357-358 for spinal anesthesia, 235-236, 241 Celiac plexus block, for chronic pain transient neurologic symptoms from, management, 447-452 23y5= -2362 , 232 8 Central nervous system dysfunction after Burn surgery as risk factor for acute renal anes»<tth esi» a, in gyeerri atriacle patienotnt, failure, 710 59-70 clinical presentations, abnormal reflexes, 63 cognitive dysfunction after cardiac Calcium channel antagonists, in kidney surgery, 64 transplant surgery, 938 cognitive dysfunction after non- Calcium channel blockers, for prevention cardiac surgery, 64-65 of renal failure, 713, 731 death, 62-63 for renal preservation, 753-757 delirium, 63-64 976 CUMULATIVE INDEX 2000 Central nervous system dysfunction after Cocaine, for local anesthesia, 226 anesthesia (Continued) Codeine, in palliative care, 190 ISPOCD study, 65 Cognitive dysfunction, from CNS methodologic problems in the dysfunction after anesthesia, 64-65 detection of cognitive Cohort studies, prospective, in outcomes dysfunction, 65 research, 635 postoperative cognitive dysfunction, retrospective, In outcomes research, 636 64 Combined spinal-epidural technique, stroke, 63 267-295 mechanisms of, extensive loss of brain clinical experience with, 268-276 tissue, 60 for cesarean section, 269-273 hypoperfusion, 60-61 for day case surgery, 269 hypoxemia, 61 for general surgery, 268 infarction, 60 in labor, 273-27 6 risk factors, 61-62 tor orthopedic surgery, 269 spinal cord damage associated with controversial aspects of, controlling up- central blocks, 62 per level of block,| 277 y BOB 8 prevention of, 66 decreased risk of postdural puncture Cerebral death, from CNS damage during headache, 282-284 - anesthesia, 62 65 epidural test-doses, 284-285 Cerebral protection, in cardiopulmonary fetal and neonatal effects, 281 resuscitation in the elderly, 153 pressure changes in epidural and suba- ervical facet, median branch blocks, for rachnoid spaces, 279-281 chronic pain management, 432 risk of catheter penetration through 434-435 dural hole, 276-277 esarean section, combined spinal risk of meningitis, 281 282 epidural block for, 269-273 transdural drug transport, 278-279 general vs. regional anesthesia for 395 for labor, 387 396 special equipment for, 285-287 postcesarean anaigesia for 396—397 omplement system, modulation of, for spinal vs. epidural anesthesia for, 396 renal preservation, 763-764 hemotherapeutic-immunosuppressive Conduction blockade, physiology of agents, as risk factor for acute renal 218-219 failure, 708 ongestive heart failure, preoperative hildren. See Pediatric patients; Pediatrics evaluation, for kidney transplant Chloroprocaine, for local anesthesia, 225 surgery, 922-923 hronic pain management, common nerve onnective tissue stiffening, as effect of blocks in. See Nerve blocks, common, in cardiovascular and autonomic aging, hronic pain management 35-38 irculation, in geriatric patients, and effect onstipation, in terminally ill patients on cardiopulmonary resuscitation 194-195 149-150 ontinuity of care, in perioperative irculatory overload, as complication of medicine program, 525 transurethral resection of prostate ontinuous regional anesthesia, for 891-892 ambulatory surgery, 348-350 isatracurium, pharmacology of, in elderly Contoured supine position, advantages of, patients, 24 in aged patients, 116-117 lonidine, in epidural anesthesia, 262 Convection, in dialysis, 855 with local anesthetics for lower extrem Coronary artery disease, preoperative ity nerve blocks, 337 evaluation, for kidney transplant for prolonging upper extremity nerve surgery, 922 blocks, 306-307 orticosteroid therapy as risk for with spinal anesthesia, 246 anesthesia in pediatric patients, 609 oagulation, neuraxial labor analgesia Cough, in terminally ill patients, 197-198 and, 393-394 Critical care, in community hospital oagulopathy, as complication of practice, 543-544 transurethral resection of prostate, 894 and perioperative medicine, 527-538 correction of, for patients with chronic current perspective, 529-530 renal failure, 875 current state of the specialty, 530-531 uremic, preoperative evaluation, for kid- demographic changes and practitioner ney transplant surgery, 926-927 requirements, 529 CUMULATIVE INDEX 2000 historical perspective, 527-529 Diabetes, complications from, in kidney practice models, 5 33 3-5=3 6 transplant surgery, 941-942 training paradigm, 531-533 preoperative evaluation, for kidney perioperative medicine program, 524 transplant surgery, 923-924 vis Dialysis, 853-862 Croup, postintubation, in pediatric acute and chronic fluid shifts, 859-860 patients, 617 basic mechanisms of, 853, 855 Cryosurgery, as alternative to transurethral convection, 855 resection of prostate, 895 diffusion, 855 Cyclosporine A, vasomotor nephropathy osmosis, 855 trom, S05 for chronic renal failure, 874, 880 Cystectomy radical, anesthetic forms of therapy in, hemodiafiltration, considerations, 902 854, 857 preoperative considerations, 901-902 hemodialysis, 855-857 radical prostatectomy nephrectomy hemofiltration, 854, 857 pheochromocytoma, and laparo- peritoneal dialysis, 858 scopic procedures, anesthesia for, ultrafiltration, 854, 857-858 899-917 intermittent vs. continuous therapy 858 859 for renal insufficiency, 784-785 surgery in patients on, 860 861 in outcomes research, Diarrhea, in terminally ill patients, 196 Dibucaine, for local anesthesia, 229-230 Databases, in outcomes research, 636-637 Diffusion, in dialysis, 855 Data management, for perioperative Diltiazem, for renal preservation, 756 medicine practice, 647-661 Diuretic resistance, strategies for nstructing a perioperative overcoming, 749-750 ntormation system, 649-650 types of, 748-749 ronic record design and Jiuretics, classification of, 745 implementation issues, data in kidney transplant surgery, 937-938 standards and information loop, for oliguria, 746 oding, 655-656 for renal insufficiency, 783 dware issues, 658-659 for oliguria, atrial natriuretic peptide rchase or develop a system, 658 747-748 urity, 656-655 dopamine, 746-74; cting important data, 656 dopaminergic agonists, 746 » and implementation issues fenoldopam, 4; Hho 660) loop diuretics, 746 of data collection, 647-649 mannitol, 744, 746 care documentation and renal benefits, 744 professional billing, 648 Dobutamine, dopamine used with, 846 evidence-based medicine, 649 Do-not-resuscitate orders in operating stems for recording and reporting room, for geriatric patients, 167-171 perioperative information Dopamine, for intraoperative prevention advanced solution, 652-655 of renal failure 729-731 ntermediate solution, 651-652 in kidney transplant surgery, 938-939 simple solution, 650-651 ]L OW dose renal,”” 835-851 case surgery, combined spinal- animal studies, 841 epidural block for, 269 in combination therapy, 846 Decision analysis, in business of in crossover trial, 846 perioperative medicine, 689-690 equivocal evidence, 841, 845 Jecuditl as complication of positioning for established acute renal failure, aged patients, 113-114 845-846 elirium, from CNS dysfunction after history, 836 anesthesia, 63-64 and oliguric vs. nonoliguric renal fail- in terminally ill patients, 200 ure, 841 Dementia, in terminally ill patients in patients at risk for acute renal fail- 199. 200 ure, 845 Depression, in terminally ill patients pharmacodynamics, 837-840 198-199 pharmacokinetics, 836-8372 978 CUMULATIVE INDEX 2000 Dopamine (Continued) local anesthetic drugs, 260 positive evidence for, 841, 842-844 novel analgesic drugs, 261 rationale for use, 840 opioid analgesics, 261 side effects, 840-841 equipment, C atheters, 2 59 statistical power of renal dopamine needles, 251 959 studies, 845 methods of determining extent of in management of renal insufficiency epidural anesthesia, 257-258 772823 patient-controlled epidural for oliguria, 746-747 analgesia, 258-259 for prevention of acute renal failure techniques, epidural radiographs Dopamine, agonists, for renal and epiduroscopy, 256--257 preservation, 761-763 epidural saline injection to hasten Dopaminergic agonists, for oliguria, 746 return of postoperative motor Dopexamine, in kidney transplant surgery function, 2 55-256 Q20 needle and catheter insertion Dysphagia, from intrathecal analgesia, techniques, 252-254 388-389 unilateral epidural analgesia Dyspnea, in terminally ill patients, 196-197 techniques, 255 verification of catheter location 254-255 > of, In postoperative outcome Edema pulmonary, in postoperative 407-428 pediatric patients, 618-619 benefits of IV-PCA, 409 Edmonton symptom assessment scale, 186 blood loss and thromboembolism Electrolyte balance, fluid and, in patients 423 with chronic renal failure, 864-868 defining surgical outcome, 410 Electrolyte changes, physiologic acid base epidural issues, 409-410 and. See Acid-base and electrolyte gastrointestinal motility, 424426 1ANEeS, } whM YSIOiLoOlQoIeC , IN , acute } € awniU dn d chrcrh io n ’ immune system, 423-424 renal failure patients neuroendocrine stress response Emergence phenomena, after general 421-423 anesthesia, in pediatric patients pain relief, 408-409 615-616 physiologic sequelae of surgery, End of life issues, anesthesiologist s 408 involvement in, 172-175 pulmonary outcome, 418-421 palliative care and. See Palliat regional vs. general anesthesia in ind end of life issues vascular surgery, 410-413 Endovascular aortic stents, for prevention thoracic epidural anesthesia and of renal failure, 733-734 myocardial ischemia, 414418 End-stage liver disease, in pathogenesis of complications of, 461-485 renal insufficiency, 779-780 anterior spinal artery syndrome, 468 Epidural abscess, after epidural anesthesia incidence and etiology of, 462, 463 477-478, 480 local anesthetic toxicity, 465-466 Epidural analgesia, for labor, epidural test meningitis and spinal abscess, 474 dose, 391-392 478, 479-480 individualized approach to, 390-391 nerve injury from needle and catheter low dose techniques and patient- placement, 462, 464 controlled epidural analgesia neuraxial block in patients with preex- 389-390 isting neurologic disorders, 480 in perioperative pain management, 581 481 582 performance of neuraxial block in pa- complications, 583-584 tients under anesthesia, 481-482 controversial issues, 584 postdural puncture headache, 464—465 potential benefits, 582-583 spinal hematoma, 468 Epidural anesthesia, and analgesia, new antiplatelet medications, 473-474 developments in, 251-266 intravenous and subcutaneous stan- anesthetic and analgesic drugs, dard heparin, 470-471 259-263 low molecular weight heparin, 471 liposome-encapsulated analgesics, 472 24625 oral anticoagulants, 472-473 CUMULATIVE INDEX 2000 979 transient neurologic symptoms, 466 Facet blocks, for chronic pain 468 management, 430-431 herpes simplex virus and, 478-479 Fasting guidelines preoperative, tor HIV and, 479 pediatric patients, 612-613 Vs spinal anesthesia, for cesarean sec- Felodipine, for renal preservation, 755-756 tion, 396 Femoral nerve block, 32 6, 328 pidural space, pressure changes in, from complications, 329 combined spinal-epidural technique in pediatrics, 372 279-281 technique, 328-329 pidural steroid injection, for chronic pain Fenoldopam, for oliguria, 747 management, 438-439 for renal preservation, 761-763 pidural test-doses, with combined spinal- Fentanyl, as opioid analgesic, 261 epidural technique, 284-285 in palliative care, 191-192 piduroscopy, 256-2 J/ pharmacology of, in elderly patients pinephrine, in cardiopulmonary 14-15 resuscitation in the elderly, 150-151 with spinal anesthesia, 236, 245-246 with local anesthetics for lower extrem Fetal effects, from combined spinal- ity nerve blocks, 337 epidural technique, 281 for prolonging upper extremity nerve Fetal heart rate effects, of intrathecal bloc ks, 306 analgesia, 387-388 with spinal anesthesia, 245 sters for local anesthesia, benzocaine, 226 Finance, in business of perioperative medicine, 691 692 2 chloroprocaine, 225 Fluid and electrolyte balance, in patients ocaine, 226 with chronic renal failure, 864-868 procaine, 224 tetracaine, 225-226 Fluid imbalance, in patients with chronic thical decisions in perioperative eldet renal failure 864 Ccar©re 159-181 Fluid resuscitation, impact of, on renal advance directives, 164-167 outcome 741-742 inesthesiologist’s involvement in end-of Furosemide, dopamine used with, 846 life care, 172-175 for p7r9e9v ention of renal failure, 712, 728 sthesiologist’s stake in medical eth- ics, 176 177 »t-resuscitate orders in operating room, 167-171 Gas € xchange impaired ethiciency of, in ethical principles and the concept of per- elderly, 52-53 sonhood, 160-162 Gastric aspiration prophylaxis, for kidney informed consent, 162-164 transplant surgery, 928 resource allocation, 176 Gastrointestinal dysfunction, in patients eatment redirection and palliative care with chronic renal failure, 870 171-172 views of aging, 159 160 Gastrointestinal motility, with epidural I t idocaine, for local anesthesia, 22 29 anesthesia and analgesia, 424-426 I it} hanasia, 172, 174, 175 Gastrointestinal sy mptoms, in terminally I xt racorporeal shock wave lithotripsy ll patients, 194-196 anesthetic considerations for, in General anesthesia improvements in 99-100 children, 961 immersion physiology and concerns for patients with chronic renal failure, 960-961 877-879 pain 956-960 spinal anesthesia vs., 236 complications and special considera- vs. regional anesthesia, for cesarean sec- tlons 961-964 tion, 395-396 bowel and spleen, 963 General surgery, combined spinal-epidural heart, 963 block for, 268 hypertension, 962-963 General vs. regional anesthesia, choosing, kidney, 962 for the elderly, 91-104 vascular, 963-964 anesthesia-related complications, fundamental lithotriper concepts, 954, 95-96, 97-98 955-956 difference between the late 1970s and percutaneous nephrolithotomy, 953- and the late 1990s, 96-101 971 early perceptions, 94 980 CUMULATIVE INDEX 2000 General vs. regional anesthesia (Continued) HIV, spinal and epidural anesthesia and, Hierarchy of Questions about, 91-92 479 perioperative mortality and Hospic e care, 185 morbidity in older patients, Hospitalist teams, in community hospital 93-94 practice, 547-549 recent studies, 96 Hydrocodone, in palliative care, 190 Geriatric anesthesia, autonomic and Hydromorphone, in palliative care, 191 cardiovascular function in the geriatric Hyperkalemia, diagnosis, 821 patient, 31-46 pathophysiology, 819-820 central nervous system dysfunction after in patients with chronic renal failure anesthesia in the geriatric patient 979 59-70 treatment, 821, 876 choosing general vs. regional anesthesia Hypermagnesemia, diagnosis, 829 for the elderly, 91-104 pathophysiology, 828-829 ethical decisions in perioperative elder treatment, 829 care, 159-181 Hypernatremia, diagnosis, 818 geriatric pain management 123-141 pathophysiology, 817-818 issue on, 1-215 treatment, 818-819 management of cardiopulmonary resus Hyperphosphatemia, diagnosis, 829 citation 143-158 pathophysiology, 829 palliative care and end of life issues treatment, 829-830 183-208 Hypertension, after extracorporeal shock pharmacology of anesthetic drugs in el wave lithotripsy in, 962-963 derly patients, 1-29 as complication of kidney transplant sur- positioning aged patients, 105-121 gery, 940 preoperative assessment of the elderly control of, for patients with chronic re- patient, 71-89 nal failure, 875-876 > respiratory function in the elderly, 47-5§ intraoperative, in patients with chronic Glycine toxicity, as complication of renal failure, 879 transurethral resection of prostate, 892 preoperative evaluation, for kidney Grief stages otf 203-204 transplant surgery, 923 Growth factors, for prevention of acute Hypnotics, pharmacology of, in elderly ae 8 renal failure, 713 patients, 5-14 for renal repair and regeneration, 765 Hypocalcemia, diagnosis, 823-824 pathophysiology, 821, 823 treatment, 824-826 Hypomagnesemia, diagnosis, 827 Head-down tilt, disadvantages of, in aged pathophysiology, 826-827 patients, 115-116 treatment, 827-828 Heart, affected by extracorporeal shock Hyponatremia, clinical features, 813 wave lithotripsy, 963 as complication of transurethral resec Hematologic alterations, in patients with tion of prostate, 891-892 chronic renal failure, 869 Hemodiafiltration, in dialysis, 854, 857 diagnosis, 814-815 Hemodialysis procedure, 855-857 pathophysiology, 81 } Hemodynamic management, effects of treatment, 815-817 anesthesia and in geriatric patient Hypo-osmolality, as complication of 4041 transurethral resection of prostate Hemofiltration, in dialysis 854, 857 891-892 Hemoglobin, as risk factor for acute renal Hypoperfusion, as cause of CNS failure, 709 dysfunction after anesthesia, 60-61 Heparin, intravenous and subcutaneous as complication of positioning aged pa- spina! hematoma and, 470-471 tients, 114-115 low molecular weight, spinal hematoma Hypotension, as complication of kidney and, 471-472 transplant surgery, 941 Hepatorenal syndrome, as vasomotor management of, in geriatric patient nephropathy, 802-803 42-43 Herpes simplex virus, spinal and epidural maternal, and regional anesthesia for ob- anesthesia and, 478-479 stetrics, 397—400 Herpes zoster, postherpetic neuralgia from Hypothermia, as anesthesia-related 132-135 complication, 95 CUMULATIVE INDEX 2000 981 as complication of positioning aged pa- Intubation-related complications, in tients, 113 pediatric patients, 616-617 as complication of transurethral resec- Irrigation solutions, absorption of, as tion of prostate, 894 complication of transurethral resection Hypovolemia, oliguria and, 739-740 of prostate, 891 as risk factor for acute renal failure, 707 for transurethral resection of prostate, Hypoxemia, as cause of CNS dysfunction 884-885 after anesthesia, 61 Isolated peripheral nerve blocks, for upper Hypoxia, medullary, in pathogenesis of extremity regional anesthesia, 313-314 renal insufficiency, 776-778 Jaundice, cholestatic, as risk factor for Ileus, postoperative, 576-577 acute renal failure, 707 llioinguinal and iliohypogastric nerve postoperative, in pediatric patients, 626- 5 block, in pediatrics, dosing, 367 1°) risks, complications, contraindications, Juxtaglomerular apparatus, in normal 368 regulation of renal perfusion, 792 technique, 367 Immune system, preservation of, with epidural anesthesia and analgesia, 423-424 Ketamine, in epidural anesthesia, 262 Immunosuppressants, anesthetic Kidney, conditions involving, after implications of, in kidney transplant extracorporeal shock wave lithotripsy, surgery, 943, 944 962 Induction agents, intravenous, for kidney harvested, preservation of, 933 transplant surgery, 929 Kidney cocktail, in kidney transplant Infarction, as cause of CNS dysfunction surgery, 939 after anesthesia, 60 Kidney donors, cadaveric, management of, Information management system 932-933 perioperative, 520-521 living, management of anesthesia for, 932 Informed consent, in elderly population, Infrac1l6a2v-i1c6u4l ar block, for upper extremity Kidnepyr evpeenrtfiuosna te,of froern ali ntfraailoupreer,a t7i3v2e- 73:+h >e] regional anesthesia, 310-311 Kidney recipients, anesthetic management Inguinal perivascular block, for lumbar of, 933 plexus block, 320-321, 322 Kidney transplant surgery, anesthesia for, Inhalational agents, for kidney transplant 919-951 surgery, 929-930 anesthetic implications of immunosup- Interscalene block, for upper extremity pressants, 943, 944 regional anesthesia, 308-309 candidates for, 919-920 Intracardiac shunts, as risk for anesthesia contraindications to, 919, 920 in pediatric patients, 607 factors affecting viability in, albumin, ntracranial pathology, affecting 935-937 positioning of aged patients, 112-113 anesthetic management of kidney re- Intraoperative care, in community hospital cipients, 933 practice, 541 calcium channel antagonists, 938 in perioperative medicine program, 523 diuretics, 937-938 Intrathecal adjuncts, with spinal dopamine, 938-939 anesthesia, 236, 245-246 dopexamine, 939 Intrathecal analgesia, for labor, 384-387 intravascular volume, 933-935 adverse effects of, fetal heart rate kidney cocktail, 939 effects, 387-388 management of anesthesia for living high block, respiratory depression, kidney donors, 932 and dysphagia, 388-389 management of cadaveric kidney do- pruritus, 389 nor, 932-933 Intravascular volume, in kidney transplant mannitol, 938 surgery, 933-935 mechanical and other causes for intra- Intravenous regional anesthesia, for upper operative anuria and oliguria, extremity nerve blocks, 312-313 939-940 982 CUMULATIVE INDEX 2000 Kidney transplant surgery (Continued respiratory effects, 908-910 preservation of harvested organ, 9 >,]> Laser prostatectomy, as alternative to intraoperative complications cardiovas transurethral resection of prostate, 895 cular complications, 940 itex allergy in pediatric patients, 610-612 diabetes and intraoperative course Lawn chair position, advantages of, in set 941-942 , aged patients, 116-11 hypertension, 940 I eadership in business ot pe rioperative hypotension, 941 medicine, 684-685 intraoperative potassium and glucose evobupivacaine, for epidural anesthesia levels, 941 261 sickle cell disease, 942 for local anesthesia, 230 perioperative management, gastric as} evorphanol, in palliative care, 192 ration prophylaxis, 928 idocaine, for local anesthesia, 226—22 inhalational agents, 929-930 for spinal anesthesia, 235, 241 intravenous induction transient neurologic symptoms from monitoring, 928-929 23 a5!, dam23e muscle relaxants, 93 iposome-encapsulated anI algesics pserleemcetdiiocn atoifo na,n est9h2e7s-i9a2, 8 9 927 epidural anesthesia, ~ ] 263 ithotripsy, extracorporeal shock wave. See use of opioids in patients with ure Extracorporeal shock Wa er ee mia, 930 iver disease, end-stage, in pathogenesis postoperative management, emergence f renal insufficiency, 779-780 and immediate postoperative iver failure, as vasomotor nephropathy course, 943 802—803 long-term outcome, 945 iver transplantation, as risk factor fo preoperative evaluation, 920-927 cardiac disease, 922 acute renal failure, 710 chronic anemia, 925 976 Living wills, 164-165, 201 congestive heart failure 922 Local anesthetics, for lower extremity coronary artery disease, 9 nerve blocks, 319-340 diabetes mellitus, 923-924 idditives, 337 hypertension, 923 clonidine, 337 serum potassium, 924 epinephrine, 337 uremic coagulopathy, 926-92 =a sodium bicarbonate, 337 Knee nerve blocks at, 333311 concentration, 336 duration, 336 pharmacology basic nerve 217-218 Labor analgesia, adve biochemistry of 387-389 cules, 220 umbulating with, 392 ille a" 224 combined spinal-epidural an v94 722_9/70 , cardiac toxicity, 223 direct tissue toxicity epidural, 389-392 lipid solubility, 221 intrathecal analgesia, 384 pain pathways in labor methemoglobinemia therapy 383-384 pKa, 221-222 rol“e taoef combined spinal-, e protein binding, 221 nique, 387 toxicity, 222-223 Laparoscopic procedures, anesthetic physiology of conduction blockade management, analgesia, 912 218-219 anesthteh tic agents 911-912 spt ecific agents amides, bupiv acaine anesthetic technique, 911 228-229 antiemesis, 912-913 dibucaine, 229-230 complications, 913 etidocaine, 229 monitoring, 910-911 levobupivacaine muscle relaxants, 912 lidocaine, 226-227 preoperative evaluation, 910 mepivacaine, 227-228 cardiovascular effects, 907-908 prilocaine, 229 radical prostatectomy, cystectomy, 1 ropivacaine, 230 phrectomy, and pheochromocytoma esters, benzocaine, 226 anesthesia for, 899-917 2-chloroprocaine, 225